Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial

1. Moreso, F.
2. Crespo, M.
3. Ruiz, J.C.
4. Torres, A.
5. Gutierrez-Dalmau, A.
6. Osuna, A.
7. Perelló, M.
8. Pascual, J.
9. Torres, I.B.
10. Redondo-Pachón, D.
11. Rodrigo, E.
12. Lopez-Hoyos, M.
13. Seron, D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1111/AJT.14520 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus